A Study to Evaluate the Effect of IV Doses of Rivipansel in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function

Conditions

• Moderate Hepatic Impairment
• Normal Hepatic Function

Interventions

• DRUG: Rivipansel

Sponsor

GlycoMimetics Incorporated